<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Lecithin:cholesterol acyltransferase (LCAT) is responsible for cholesterol esterification in plasma </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations of LCAT gene cause familial <z:e sem="disease" ids="C0268239" disease_type="Disease or Syndrome" abbrv="">LCAT deficiency</z:e>, a <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorder</z:e> characterized by <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="39015">Apolipoprotein</z:chebi> B (apoB) is the main protein component of <z:chebi fb="0" ids="39027">very-low-density lipoproteins</z:chebi> and <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>Mutations of APOB gene cause familial <z:hpo ids='HP_0003563'>hypobetalipoproteinemia</z:hpo>, a codominant disorder characterized by low plasma levels of <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> and apoB </plain></SENT>
<SENT sid="4" pm="."><plain>OBJECTIVE: This was a genetic and biochemical analysis of an Italian kindred with <z:hpo ids='HP_0003563'>hypobetalipoproteinemia</z:hpo> whose proband presented with <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> and severe <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Plasma <z:chebi fb="23" ids="18059">lipids</z:chebi> and <z:chebi fb="0" ids="39015">apolipoproteins</z:chebi>, cholesterol esterification, and <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) subclass distribution were analyzed </plain></SENT>
<SENT sid="6" pm="."><plain>LCAT and APOB genes were sequenced </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The proband had severe impairment of plasma cholesterol esterification and high preÎ²-<z:chebi fb="17" ids="39025">HDL</z:chebi> content </plain></SENT>
<SENT sid="8" pm="."><plain>He was heterozygote for the novel LCAT P406L variant, as were two other family members </plain></SENT>
<SENT sid="9" pm="."><plain>The proband's wife and children presented with familial <z:hpo ids='HP_0003563'>hypobetalipoproteinemia</z:hpo> and were heterozygotes for the novel apoB H1401R variant </plain></SENT>
<SENT sid="10" pm="."><plain>Cholesterol esterification rate of apoB H1401R carriers was reduced, likely attributable to the low amount of circulating <z:chebi fb="15" ids="39026">LDL</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>After renal transplantation, proband's <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, <z:chebi fb="17" ids="39025">HDL</z:chebi> subclass distribution, and plasma cholesterol esterification were almost at <z:mpath ids='MPATH_458'>normal</z:mpath> levels, suggesting a mild contribution of the LCAT P406L variant to his pretransplantation severe <z:e sem="disease" ids="C0473527" disease_type="Disease or Syndrome" abbrv="">hypoalphalipoproteinemia</z:e> and impairment of plasma cholesterol esterification </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: LCAT P406L variant had a mild effect on <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, <z:chebi fb="17" ids="39025">HDL</z:chebi> subclass distribution, and plasma cholesterol esterification </plain></SENT>
<SENT sid="13" pm="."><plain>ApoB H1401R variant was identified as possible cause of familial <z:hpo ids='HP_0003563'>hypobetalipoproteinemia</z:hpo> and resulted in a reduction of cholesterol esterification rate </plain></SENT>
</text></document>